End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study.
Negative PET scans after treatment strongly predict longer survival in an aggressive type of lymphoma, validating their use for prognosis.
End-of-treatment PET/CT complete remission predicted significantly longer progression-free and overall survival in nodal peripheral T-cell lymphoma across a large Australasian-Canadian multicenter collaborative cohort. EOT-PET negativity is validated as a strong independent prognostic marker in this aggressive lymphoma subtype.
What the study was
- Study design
- multicenter_retrospective_cohort
- Category
- hematologic_malignancies
- Maturity
- Validated
Why it surfaced
International multicenter study in PTCL, an aggressive lymphoma with poor prognosis and limited treatment options. Validates a widely available imaging biomarker for response assessment. Published in British Journal of Haematology, the leading UK hematology journal.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.